BPIFB4 and infection: Compared to control, AAV-RV-BPIFB4 significantly increased systolic blood pressure (SBP) two days after infection; SBP reached a maximum at day 3 and returned to a level that was not significantly different from baseline at day 4 (Fig. 2A).